Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | RAB9A | P51151 | 6/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | CA7 | P43166 | 1/20 | 0.57 |
| ▸ | CA9 | Q16790 | 1/20 | 0.57 |
| ▸ | LTA4H | P09960 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 5/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27888211 | 0.94 | LTA4H (0.66) | TDP1TSHRRAB9AMAPTMEN1 | |
| SCHEMBL5380417 | 0.94 | RAB9A (0.60) | TDP1TSHRRAB9AMAPTMEN1 | |
| SCHEMBL112238 | 0.91 | TSHR (0.67) | TDP1TSHRRAB9AMAPTKMT2A | |
| Diethylamine SCHEMBL1284722 | 0.90 | TDP1 (0.55) | TDP1TSHRRAB9AMAPTMEN1 | |
| SCHEMBL7934865 | 0.90 | LTA4H (0.56) | TDP1TSHRRAB9AMAPTMEN1 | |
| SCHEMBL25877289 | 0.88 | MEN1 (0.54) | TDP1TSHRRAB9AMAPTMEN1 | |
| Formic Acid SCHEMBL27886420 | 0.88 | TDP1 (0.53) | TDP1TSHRRAB9AMAPTMEN1 | |
| 1,4-Dipropoxybenzene SCHEMBL122039 | 0.87 | LTA4H (0.67) | RAB9AMAPTMEN1KMT2ACA12 | |
| SCHEMBL12012139 | 0.87 | APP (0.57) | TDP1TSHRRAB9AMAPTMEN1 | |
| SCHEMBL11522755 | 0.87 | APP (0.57) | TDP1TSHRRAB9AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 714 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118085890-A | Liquid crystal aligning agent and preparation method and application thereof | 合肥中聚和成电子材料有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117866199-B | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element thereof | 烟台三月科技有限责任公司 | 2024-05-28 | — | — | CN | claimed |
| CN-117916657-A | Liquid crystal aligning agent, liquid crystal alignment film, method for manufacturing liquid crystal display element, and liquid crystal display element | 日产化学株式会社 | 2024-04-19 | — | — | CN | claimed |
| CN-117866199-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element thereof | 烟台三月科技有限责任公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117753235-A | Preparation method and application of block polyimide asymmetric membrane | 天津理工大学 | 2024-03-26 | — | — | CN | claimed |
| CN-114761487-B | Polymer composition, liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and method for manufacturing liquid crystal display element | 日产化学株式会社 | 2024-02-20 | — | — | CN | claimed |
| CN-112888726-B | Novel amic acid oligomer process for molding polyimide composites | 钟化美洲控股公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116814278-A | Liquid crystal aligning agent, liquid crystal alignment film prepared by using the same and display element containing the alignment film | 合肥中聚和成电子材料有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-116655673-A | Boron-nitrogen coordination bond-containing spiro compound and organic electroluminescent device | 江汉大学 | 2023-08-29 | — | — | CN | claimed |
| CN-116655672-A | Boron-nitrogen compound and organic electroluminescent device | 江汉大学 | 2023-08-29 | — | — | CN | claimed |
| US-20040110778-A1 | Heterocyclic compounds as ligands of the GABAA receptor | YOHANNES DANIEL (US) | 2004-06-10 | — | — | US | claimed |
| EP-1325006-A2 | HETEROCYCLIC COMPOUNDS AS LIGANDS OF THE GABA A? RECEPTOR | NEUROGEN CORPORATION (US) | 2003-07-09 | — | — | EP | claimed |
| US-20030105081-A1 | Heterocyclic compounds as ligands of the GABAA receptor | PFIZER INC | 2003-06-05 | — | — | US | claimed |
| EP-0873989-B1 | Process for the preparation of distyryl-biphenyl compounds | CIBA SC HOLDING AG (CH) | 2002-03-20 | — | — | EP | claimed |
| WO-2002012442-A2 | HETEROCYCLIC COMPOUNDS AS LIGANDS OF THE GABAA RECEPTOR | NEUROGEN CORPORATION (US) | 2002-02-14 | — | — | WO | claimed |
| US-5952524-A | Process | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-09-14 | — | — | US | claimed |
| CN-1198435-A | Method for producing fluorescent whitening agent | CIBA GEIGY AG (CH) | 1998-11-11 | — | — | CN | claimed |
| EP-0873988-A2 | Process for the preparation of distyryl-biphenyl compounds | Ciba SC Holding AG (CH) | 1998-10-28 | — | — | EP | claimed |
| EP-0873989-A2 | Process for the preparation of distyryl-biphenyl compounds | Ciba SC Holding AG (CH) | 1998-10-28 | — | — | EP | claimed |
| US-3953510-A | Method for the preparation of alkoxyanilines | OLIN CORPORATION (US) | 1976-04-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105081-A1 | Heterocyclic compounds as ligands of the GABAA receptor | GABRB1, GABRP, GABRA1 | TDP1 2846/4885TSHR 252/4885RAB9A 962/4885 |
| US-20040110778-A1 | Heterocyclic compounds as ligands of the GABAA receptor | GABRB1, GABRP, GABRA1 | TDP1 2846/4885TSHR 252/4885RAB9A 962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.